HEALTH.2012.1.2-1
HEALTH.2012.1.2-1
14 projects · €73,332,489 total EU contribution (project-level) · 131 participating organizations · 25 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€73,332,489
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (27)
- Netherlands (15)
- Italy (14)
- France (12)
- UK (12)
- Spain (6)
- CH (5)
- BE (4)
- HU (4)
- SE (4)
- AT (3)
- EL (3)
- CY (2)
- CZ (2)
- DK (2)
- FI (2)
- IE (2)
- IL (2)
- NO (2)
- US (2)
- EE (1)
- LT (1)
- MD (1)
- RO (1)
- RS (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ERASMUS MC3 projects · NL
- Fraunhofer3 projects · DE
- UT2 projects · DE
- BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS2 projects · EL
- INSTITUT GUSTAVE ROUSSY2 projects · FR
- INSERM2 projects · FR
- KLINIKUM DER UNIVERSITAET ZU KOELN2 projects · DE
- LMU MUENCHEN2 projects · DE
- MU2 projects · CZ
- REGIONH2 projects · DK
- UMIL2 projects · IT
- UNIVERSITY COLLEGE LONDON2 projects · —
Projects
Page 2 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Diagnosis and Monitoring of Inflammatory and Arthritic diseases using a COmbined approach Based on Ultrasound, optoacoustic and hyperSpectral imaging IACOBUS · 305760 | FP7 | €3,046,476 | €3,837,268 | Details |
Adapting Breast Cancer Screening Strategy Using Personalised RiskEstimation ASSURE · 306088 | FP7 | €5,608,544 | €7,235,027 | Details |
IMPROvED: IMproved Pregnancy Outcomes by Early Detection; personalized medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome IMPROvED · 305169 | FP7 | €5,995,390 | €7,778,526 | Details |
Multimodular biomarker analysis workflow for diagnosis, prognosis and monitoring of drug treatment response in bladder cancer"" DIPROMON · 306157 | FP7 | €3,492,217 | €4,596,144 | Details |